Back to Search Start Over

Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system

Authors :
Annika Giese
Marc Lütgehetmann
Tassilo Volz
Dominik Nörz
Nora Goldmann
Julian Schulze zur Wiesch
Lisa Sophie Pflüger
Dieter Glebe
Maura Dandri
Katja Giersch
JH Bockmann
Susanne Pfefferle
Source :
JHEP Reports, JHEP Reports, Vol 3, Iss 6, Pp 100356-(2021)
Publication Year :
2021

Abstract

Background & Aims Currently available HDV PCR assays are characterized by considerable run-to-run and inter-laboratory variability. Hence, we established a quantitative reverse transcription real-time PCR (RT-qPCR) assay on the open channel of a fully automated PCR platform (cobas6800, Roche) offering improved consistency and reliability. Methods A primer/probe-set targeting a highly conserved region upstream of the HDV antigen was adapted for use on the cobas6800. The lower limit of detection (LLOD) was determined using a dilution panel of the HDV WHO standard (n = 21/dilution). Linearity and inclusivity were tested by preparing 10-fold dilution series of cell culture-derived virus (genotype [GT]1-8; n = 5/dilution). Patient samples containing a variety of bloodborne viral pathogens were tested to confirm exclusivity (n = 60). Results The LLOD of the HDV utility-channel (HDV_UTC) assay was determined as 3.86 IU/ml (95% CI 2.95–5.05 IU/ml) with a linear range from 10–10ˆ8 IU/ml (GT1). Linear relationships were observed for all HDV GTs with slopes ranging from -3.481 to -4.134 cycles/log and R2 from 0.918 to 0.994. Inter-run and intra-run variability were 0.3 and 0.6 Ct (3xLLOD), respectively. No false-positive results were observed. To evaluate clinical performance, 110 serum samples of anti-HDV-Ab+ patients were analyzed using the HDV_UTC and CE-IVD RoboGene assays. 58/110 and 49/110 samples were concordant positive or negative, respectively (overall agreement 97.3%). Quantitative comparison demonstrated a strong correlation (R2 0.8733; 95% CI 0.8914–0.9609; p value<br />Highlights • Establishment and validation of new quantitative HDV PCR assay on a fully automated platform (cobas6800). • New assay allows for dynamic scaling of testing capacity and drastically reduces hands-on time as wells as manual steps. • Improved reliability and reproducibility of test results. • Lower limit of quantification of 10 IU/ml and a linear range from 101–108 IU/ml. • Inclusivity for all 8 known HDV genotypes.<br />Graphical abstract

Details

ISSN :
25895559
Volume :
3
Issue :
6
Database :
OpenAIRE
Journal :
JHEP reports : innovation in hepatology
Accession number :
edsair.doi.dedup.....a5e839701df52b68dd15dad8d579025f